{"id":58944,"date":"2017-01-16T11:51:29","date_gmt":"2017-01-16T03:51:29","guid":{"rendered":"\/\/m.catawbaoil.com\/?p=58944"},"modified":"2017-01-16T11:51:29","modified_gmt":"2017-01-16T03:51:29","slug":"2016%ef%bc%88%e7%ac%ac%e4%b8%83%e5%b1%8a%ef%bc%89%e7%bb%86%e8%83%9e%e6%b2%bb%e7%96%97%e5%9b%bd%e9%99%85%e7%a0%94%e8%ae%a8%e4%bc%9a%e9%9a%86%e9%87%8d%e5%bc%80%e5%b9%95","status":"publish","type":"post","link":"\/\/m.catawbaoil.com\/58944.html","title":{"rendered":"2016\uff08\u7b2c\u4e03\u5c4a\uff09\u7ec6\u80de\u6cbb\u7597\u56fd\u9645\u7814\u8ba8\u4f1a\u9686\u91cd\u5f00\u5e55"},"content":{"rendered":"
6\u670817\u65e5\uff0c\u7531\u751f\u7269\u8c37\u4e3b\u529e\u76842016\u5e74\uff08\u7b2c\u4e03\u5c4a\uff09\u5e72\u7ec6\u80de\u6280\u672f\u4e34\u5e8a\u5e94\u7528\u8bba\u575b\u4e8e\u6b66\u6c49\u6b27\u4e9a\u4f1a\u5c55\u56fd\u9645\u9152\u5e97\u9686\u91cd\u53ec\u5f00\u3002\u5927\u4f1a\u9080\u8bf7\u4e86\u56fd\u5185\u5916\u9876\u5c16\u7684\u7ec6\u80de\u6cbb\u7597\u57fa\u7840\u7814\u7a76\u4e13\u5bb6\u53ca\u4e34\u5e8a\u4e13\u5bb6\u4e0e\u4f1a\uff0c\u5bf9\u7ec6\u80de\u6cbb\u7597\u76f8\u5173\u7684\u70ed\u70b9\u8bae\u9898\u8fdb\u884c\u8ba8\u8bba\u3002<\/p>\n
2016(\u7b2c\u4e03\u5c4a)\u7ec6\u80de\u6cbb\u7597\u56fd\u9645\u7814\u8ba8\u4f1a\uff0c\u5c06\u7ee7\u7eed\u4ee5\u8f6c\u5316\u533b\u5b66\u4f5c\u4e3a\u5207\u5165\u70b9\uff0c\u5c06\u57fa\u7840\u7814\u7a76\u4e0e\u4e34\u5e8a\u5e94\u7528\u76f8\u7ed3\u5408\uff0c\u9080\u8bf7\u56fd\u5185\u5916\u9876\u5c16\u7684\u7ec6\u80de\u6cbb\u7597\u57fa\u7840\u7814\u7a76\u548c\u4e34\u5e8a\u4e13\u5bb6\uff0c\u7784\u51c6\u7ec6\u80de\u6cbb\u7597\u7814\u7a76\u7684\u6700\u65b0\u7814\u7a76\u52a8\u6001\u548c\u8fdb\u5c55\uff0c\u9488\u5bf9\u7ec6\u80de\u6cbb\u7597\u7684\u4e34\u5e8a\u4f26\u7406\u3001\u6cbb\u7597\u89c4\u8303\u3001\u7ec6\u80de\u5236\u54c1\u8d28\u91cf\u63a7\u5236\u3001\u65b0\u578bCAR-T\u3001CAR-NK\u3001TCR\u7597\u6cd5\u3001\u5b9e\u4f53\u7624\u6cbb\u7597\u3001\u80bf\u7624\u514d\u75ab\u68c0\u67e5\u70b9\u6291\u5236\u5242PD-1\u3001iPSCs\u4e34\u5e8a\u6cbb\u7597\u5e94\u7528\u3001\u5e72\u7ec6\u80de\u79fb\u690d\u6cbb\u7597\u3001\u57fa\u56e0\u7f16\u8f91\u3001\u57fa\u56e0\u4fee\u9970\u5316\u7ec6\u80de\u6cbb\u7597\u3001\u5fae\u56ca\u5316\u7ec6\u80de\u79fb\u690d\u6cbb\u7597\u7b49\u70ed\u95e8\u8bae\u9898\u8fdb\u884c\u8ba8\u8bba\u3002<\/p>\n
<\/p>\n
\u4eca\u65e5\u4e0a\u5348\u7387\u5148\u7531\u6765\u81ea\u5eb7\u5185\u5c14\u5927\u5b66\u7ef4\u5c14\u5eb7\u5948\u533b\u5b66\u9662\u7684\u738b\u8363\u798f\u6559\u6388\u5f00\u5c55\u9898\u4e3a\u300aCancer immunotherapy\uff1a current status and future directions\u300b\u7684\u4e3b\u9898\u6f14\u8bb2\u3002\u4ed6\u5728\u8fd9\u6b21\u6f14\u8bb2\u4e2d\uff0c\u7b80\u8981\u4ecb\u7ecd\u4e86\u4ed6\u5728\u80bf\u7624\u514d\u75ab\u6cbb\u7597\u65b9\u9762\u7684\u6700\u65b0\u7814\u7a76\u6210\u679c\uff0c\u5e76\u5728\u672a\u6765\u80bf\u7624\u514d\u75ab\u6cbb\u7597\u7684\u53d1\u5c55\u65b9\u5411\u548c\u4e34\u5e8a\u5e94\u7528\u76f8\u5173\u7b49\u65b9\u9762\u505a\u51fa\u8be6\u5c3d\u7684\u9610\u8ff0\u3002<\/p>\n
\u968f\u540e\u4e2d\u56fd\u98df\u54c1\u836f\u54c1\u68c0\u5b9a\u7814\u7a76\u9662\/\u7ec6\u80de\u8d44\u6e90\u50a8\u85cf\u53ca\u7814\u7a76\u4e2d\u5fc3\u7684\u8881\u5b9d\u73e0\u6559\u6388\u3001\u5317\u4eac\u5927\u5b66\u8840\u6db2\u75c5\u7814\u7a76\u6240\u7684\u9ec4\u6653\u519b\u6559\u6388\u3001\u56fd\u7acb\u9633\u660e\u5927\u5b66\u7684\u674e\u5149\u7533\u6559\u6388\uff0c\u5206\u522b\u4ece\u7ec6\u80de\u6cbb\u7597\u7684\u4e0d\u540c\u65b9\u5411\uff0c\u5f00\u5c55\u4e86\u9898\u4e3a\u300a\u5e72\u7ec6\u80de\u751f\u7269\u5b66\u6548\u5e94\u8bc4\u4ef7\u7684\u57fa\u672c\u539f\u5219\u300b\u7684\u6f14\u8bb2\u3002<\/p>\n
\u6765\u81ea\u6885\u65af\u533b\u5b66\/\u751f\u7269\u8c37\u7684\u6c88\u9038\u98de\u5148\u751f\uff0c\u66f4\u662f\u5728\u73b0\u573a\u53d1\u8d77\u5efa\u7acb\u7ec6\u80de\u6cbb\u7597\u591a\u4e2d\u5fc3\u6ce8\u518c\u5e73\u53f0\uff08 CTR \uff09\u7684\u6d3b\u52a8 \u3002\u6d3b\u52a8\u4e4b\u540e\uff0c\u7814\u8ba8\u4f1a\u4e3b\u8981\u5206\u4e3a\u201c\u5e72\u7ec6\u80de\u6cbb\u7597\u201d\u4e13\u573a\u548c\u201c\u514d\u75ab\u7ec6\u80de\u6cbb\u7597\u201d\u4e13\u573a\u3002<\/p>\n
\u5341\u4e03\u65e5\u4e0b\u5348\u7684\u201c\u5e72\u7ec6\u80de\u6cbb\u7597\u201d\u4e13\u573a\u7684\u5609\u5bbe\u5206\u522b\u662f\u7a0b\u4e34\u948a\u6559\u6388\u3001\u5434\u660e\u8fdc\u5148\u751f\u3001\u674e\u5149\u7533\u6559\u6388\u3001\u666f\u4e43\u79be\u6559\u6388\u3002\u6765\u81ea\u7f8e\u56fd\u970d\u666e\u91d1\u65af\u5927\u5b66\u533b\u5b66\u9662\u7684\u7a0b\u4e34\u948a\u6559\u6388\uff0c\u7b80\u8981\u4ecb\u7ecd\u4e86\u5e72\u7ec6\u80de\u5de5\u7a0b\u5728\u7cbe\u51c6\u533b\u5b66\u65f6\u4ee3\u4e2d\u7684\u7ec6\u80de\u548c\u57fa\u56e0\u6cbb\u7597\u65b0\u65b9\u6cd5\u3002\u5434\u660e\u8fdc\u5148\u751f\u5c31\u4e2d\u56fd\u7ec6\u80de\u4ea7\u4e1a\u8fdb\u7a0b\u4e0e\u65b0\u673a\u9047\u95ee\u9898\u4e0e\u5927\u5bb6\u8fdb\u884c\u4e86\u63a2\u8ba8\u3002\u674e\u5149\u7533\u6559\u6388\u53d1\u8868\u4e86\u9898\u4e3a\u201cTranslational application of mesenchymal stem cells\u201d\u7684\u6f14\u8bb2\u3002\u666f\u4e43\u79be\u6559\u6388\u8be6\u8ff0\u4e86\u5728\u963f\u5c14\u8328\u6d77\u9ed8\u75c5\u52a8\u7269\u6a21\u578b\u4e2d\u5e72\u7ec6\u80de\u6cbb\u7597\u7684\u5e94\u7528\u3002<\/p>\n
<\/p>\n
\u5341\u516b\u65e5\u7684\u201c\u5e72\u7ec6\u80de\u6cbb\u7597\u201d\u5c06\u7531\u4e13\u573a\u5609\u5bbe\uff1a\u4e2d\u79d1\u9662\u5e7f\u5dde\u751f\u7269\u533b\u836f\u4e0e\u5065\u5eb7\u7814\u7a76\u9662\u9662\u957f\u88f4\u7aef\u537f\u5e26\u6765\u300aCell Fate Decision\uff1a Mechanism and Application\u300b\u4e3b\u9898\u6f14\u8bb2\u3001\u5357\u4eac\u5927\u5b66\u533b\u5b66\u9662\u9644\u5c5e\u9f13\u697c\u533b\u9662\u4e3b\u4efb\u5b59\u51cc\u4e91\u5e26\u6765\u300a\u5e72\u7ec6\u80de\u6cbb\u7597\u81ea\u8eab\u514d\u75ab\u75c5\u7684\u5386\u53f2\u3001\u73b0\u72b6\u4e0e\u672a\u6765\u300b\u4e3b\u9898\u6f14\u8bb2\u3001\u4e0a\u6d77\u4ea4\u901a\u5927\u5b66\u533b\u5b66\u9662\u5065\u5eb7\u79d1\u5b66\u7814\u7a76\u6240\u6240\u957f\u65f6\u7389\u822b\u5e26\u6765\u300a\u95f4\u5145\u8d28\u5e72\u7ec6\u80de\u548c\u9002\u5e94\u6027\u514d\u75ab\u53cd\u5e94\u300b\u4e3b\u9898\u6f14\u8bb2\u3001\u9996\u5e2d\u897f\u6bd4\u66fc\u751f\u7269\u79d1\u6280\u96c6\u56e2\u9996\u5e2d\u8fd0\u8425\u5b98\u738b\u7acb\u7fa4\u5e26\u6765\u300a\u5145\u8d28\u5e72\u7ec6\u80de\u6cbb\u7597\u819d\u9aa8\u5173\u8282\u708e\u7684\u4e34\u5e8a\u4e0e\u5e94\u7528\u8f6c\u5316\u300b\u4e3b\u9898\u6f14\u8bb2\u3001\u540c\u6d4e\u5927\u5b66\u533b\u5b66\u9662\u9662\u957f\u5f90\u56fd\u5f64\u5e26\u6765\u300aiPSCs\u4e34\u5e8a\u6cbb\u7597\u524d\u77bb\uff1a\u773c\u75c5\u6cbb\u7597\u7387\u5148\u7a81\u7834\u300b\u4e3b\u9898\u6f14\u8bb2\u3001\u4e0a\u6d77\u4ea4\u901a\u5927\u5b66\u533b\u5b66\u9662\u9644\u5c5e\u7b2c\u4e5d\u4eba\u6c11\u533b\u9662\u526f\u9662\u957f\u66f9\u8c0a\u6797\u5e26\u6765\u300a\u591a\u80fd\u5e72\u7ec6\u80de\u4e0e\u8f6f\u9aa8\u7ec4\u7ec7\u4fee\u590d\u300b\u4e3b\u9898\u6f14\u8bb2\u3001Cedars-Sinai\u810a\u67f1\u4e2d\u5fc3\u4e3b\u4efb\u533b\u5e08 Michel F. Levesque Cedars-Sinai\u5e26\u6765\u300a\u5e72\u7ec6\u80de\u7597\u6cd5\uff1a\u6210\u4f53\u795e\u7ecf\u5e72\u7ec6\u80de\u6cbb\u7597\u5e15\u91d1\u68ee\u75c5\u300b\u3001\u6b66\u6c49\u5927\u5b66\u6559\u6388\u90d1\u5fc3\u6821\u5e26\u6765\u300a\u9aa8\u9ad3\u5e72\u7ec6\u80de\u5fae\u73af\u5883\uff08Niche\uff09\u4e0e\u79fb\u690d\u514d\u75ab\u8010\u53d7\u300b\u4e3b\u9898\u6f14\u8bb2\u3002<\/p>\n
\u5728\u201c\u514d\u75ab\u7ec6\u80de\u6cbb\u7597\u201d\u4e13\u573a\u4e2d\uff0c\u67096\u4f4d\u5609\u5bbe\u4e0e\u4f1a\u51fa\u5e2d\u3002\u738b\u8363\u5bcc\u6559\u6388\u4e3a\u5927\u5bb6\u4ecb\u7ecd\u4e86\u80bf\u7624\u514d\u75ab\u6cbb\u7597\u548c\u4e34\u5e8a\u7814\u7a76\u3001TCR-T\u7ec6\u80de\u6cbb\u7597\u65b0\u6280\u672f\u3002\u827e\u8f89\u80dc\u6559\u6388\u5bf9\u5fae\u79fb\u690d\u548cCAR-T\u8054\u5408\u6cbb\u7597\u7814\u7a76\u5c55\u5f00\u8ba8\u8bba\u3002\u94b1\u7a0b\u5148\u751f\u5bf9CAR-T\u7814\u7a76\u63d0\u51fa\u4e86\u5168\u9762\u89e3\u51b3\u65b9\u6848\u3002\u5f20\u6bc5\u6559\u6388\u4ece\u5404\u4e2a\u89d2\u5ea6\u4e3a\u5927\u5bb6\u5206\u6790T\u7ec6\u80de\u53d7\u4f53\u4ecb\u5bfc\u7684\u6297\u80bf\u7624\u514d\u75ab\u6cbb\u7597\u3002\u5218\u4e1c\u65b9\u6559\u6388\u5219\u5e26\u6765\u201cImmunological Synapse Predicts Effectiveness of Chimeric Antigen Receptor (CAR) T Cells\u201d\u7684\u7cbe\u5f69\u53d1\u8a00\u3002\u6b66\u680b\u6210\u6559\u6388\u901a\u8fc7\u8bb2\u89e3\u4e2a\u4eba\u5728\u80bf\u7624\u514d\u75ab\u7ec6\u80de\u6cbb\u7597\u4ece\u57fa\u7840\u5230\u4e34\u5e8a\u7684\u7ecf\u5386\u4f53\u9a8c\uff0c\u4e3a\u5927\u5bb6\u63d0\u4f9b\u4e86\u4e00\u7cfb\u5217\u65b9\u6cd5\u8bba\u3002<\/p>\n
\u5341\u516b\u65e5\u7684\u201c\u514d\u75ab\u7ec6\u80de\u6cbb\u7597\u4e13\u573a\u201d\u5c06\u7531\u89e3\u653e\u519b\u603b\u533b\u9662\u751f\u547d\u79d1\u5b66\u9662\u5206\u5b50\u514d\u75ab\u5b66\u7814\u7a76\u5ba4\u6559\u6388\uff0f\u4e3b\u4efb\u97e9\u4e3a\u4e1c\u5e26\u6765\u300amodification of immune cells against cancer and neoadjuvant conditioning primed cart clinical therapy\u300b\u4e3b\u9898\u6f14\u8bb2\u3001\u82cf\u5dde\u5927\u5b66\u5510\u4ef2\u82f1\u8840\u6db2\u5b66\u7814\u7a76\u4e2d\u5fc3\u6559\u6388\u6768\u6797\u5e26\u6765\u300aCAR-T\u7ec6\u80de\u6280\u672f\u5728\u5b9e\u4f53\u80bf\u7624\u5e94\u7528\u4e0a\u7684\u6311\u6218\u53caCAR-NK\u6280\u672f\u7684\u5d1b\u8d77\u300b\u4e3b\u9898\u6f14\u8bb2\u3001\u4e2d\u79d1\u9662\u5e7f\u5dde\u751f\u7269\u533b\u836f\u4e0e\u5065\u5eb7\u7814\u7a76\u9662\u7814\u7a76\u5458\u674e\u61ff\u5e26\u6765\u300a\u9ad8\u4eb2\u548cT\u7ec6\u80de\u53d7\u4f53\u4ecb\u5bfc\u7684\u7ec6\u80de\u6cbb\u7597\u6355\u6349\u75c5\u6bd2\u514d\u75ab\u9003\u9038\u300b\u4e3b\u9898\u6f14\u8bb2\u3001\u6b66\u6c49\u534f\u548c\u533b\u9662\u526f\u9662\u957f\u80e1\u8c6b\u5e26\u6765\u300aCAR-T\u7ec6\u80de\u6cbb\u7597\u7684\u4e34\u5e8a\u98ce\u9669\u53ca\u5176\u8bca\u6cbb\u7b56\u7565\u300b\u4e3b\u9898\u6f14\u8bb2\u3001\u4e2d\u56fd\u4eba\u6c11\u89e3\u653e\u519b\u603b\u533b\u9662\u6559\u6388\u5f90\u8fce\u65b0\u5e26\u6765\u300a\u8d70\u7eff\u8272\u6297\u764c\u5eb7\u590d\u4e4b\u8def-\u5efa\u7acb\u4ee5\u514d\u75ab\u6cbb\u7597\u4e3a\u6838\u5fc3\u7684\u4e2d\u897f\u533b\u6574\u5408\u5eb7\u590d\u533b\u5b66\u5e73\u53f0\u300b\u4e3b\u9898\u6f14\u8bb2\u3001\u540c\u6d4e\u5927\u5b66\u8f6c\u5316\u533b\u5b66\u9ad8\u7b49\u7814\u7a76\u7814\u7a76\u5458\u5f20\u9e3f\u58f0\u5e26\u6765\u300aCAR-T\u7ec6\u80de\u6cbb\u7597\u7684\u4e34\u5e8a\u8f6c\u5316\u548c\u5c55\u671b\u300b\u4e3b\u9898\u6f14\u8bb2\u3001\u7b2c\u4e09\u519b\u533b\u5927\u5b66\u897f\u5357\u533b\u9662\u751f\u7269\u6cbb\u7597\u4e2d\u5fc3\u6559\u6388\u94b1\u7a0b\u5e26\u6765\u300aCAR-T\u7ec6\u80de\u6cbb\u7597\u8840\u6db2\u80bf\u7624\u7684\u65b0\u7b56\u7565\u300b\u4e3b\u9898\u6f14\u8bb2 \u3001\u6e56\u5317\u7701\u4eba\u6c11\u533b\u9662\u6559\u6388\u6208\u4f1f\u5e26\u6765\u300a\u80bf\u7624\u653e\u5316\u7597\u8054\u5408\u514d\u75ab\u7ec6\u80de\u6cbb\u7597\u764c\u75c7\u7684\u4e34\u5e8a\u4f53\u4f1a\u300b\u4e3b\u9898\u6f14\u8bb2\u3001\u534e\u897f\u533b\u9662\u56fd\u5bb6\u91cd\u70b9\u5b9e\u9a8c\u5ba4\u6559\u6388\u5f20\u5fd7\u65b0\u5e26\u6765\u300a\u514d\u75ab\u7ec6\u80de\u6cbb\u7597\u7684\u5386\u53f2\u548c\u53d1\u5c55\u524d\u666f\u300b\u4e3b\u9898\u6f14\u8bb2\u3002<\/p>\n
\uff08\u672c\u6587\u8f6c\u8f7d\u81ea\u751f\u7269\u8c37\uff09<\/p>\n","protected":false},"excerpt":{"rendered":"
6\u670817\u65e5\uff0c\u7531\u751f\u7269\u8c37\u4e3b\u529e\u76842016\u5e74\uff08\u7b2c\u4e03\u5c4a\uff09\u5e72\u7ec6\u80de\u6280\u672f\u4e34\u5e8a\u5e94\u7528\u8bba\u575b\u4e8e\u6b66\u6c49\u6b27\u4e9a\u4f1a\u5c55\u56fd\u9645\u9152\u5e97\u9686\u91cd\u53ec\u5f00\u3002\u5927\u4f1a\u9080\u8bf7\u4e86...<\/p>\n